secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sarepta Therapeutics, Inc. (SRPT)
CIK:        0000873303
Form:       8-K
Filed at:   2023-03-03T23:59:59+00:00
Accession:  0001193125-23-058990
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sarepta exchanges $313.5M of 1.50% convertible notes due 2024 for common stock
------------------------------------------------------------------------------

- Approximately $313.5M aggregate principal of 1.50% Convertible Senior Notes due 2024 exchanged for shares of common stock.
- Exchange consideration: 12.2589 shares per $1,000 principal plus additional shares based on VWAP formula.
- Exchange expected to close on March 7, 2023; shares issued in private placement to accredited investors.
- Shares will be freely tradable under Rule 144; no cash paid for accrued interest.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/873303/000119312523058990/0001193125-23-058990-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/873303/000119312523058990/d478993d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-058990

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer